1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends

2015-2019 Decentralized/POC Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares, Country

  • June 2015
  • 500 pages
  • Venture Planning Group
Report ID: 3083764

Summary

Table of Contents

2015-2019 Decentralized/POC Clinical Chemistry and Immunodiagnostic Testing” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.


Rationale


The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.


Market Segmentation


- Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, structure, size, growth and major suppliers.


- Five-year test volume and reagent sales forecasts clinical chemistry procedures by market segment:



- Physician Offices/Group Practices    

- Emergency Rooms       

- Operating/Recovery Suites      

- ICUs/CCUs 

- Cancer Clinics        

- Ambulatory Care Centers        

- Surgery Centers 

- Nursing Homes

- Birth Centers


Sales and Market Share Analysis


- Sales and market shares of major reagent and instrument suppliers.


Routine Clinical Chemistry Tests


Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases,

BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes

(Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine,   GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.


Endocrine Function Tests


Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,

Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.


Therapeutic Drug Monitoring (TDM) Tests


Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate,

Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin,

Valproic Acid, Vancomycin.


Immunoprotein Tests


C3, C4, CRP, IgA, IgE Soecific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis,

and others.


Drugs of Abuse


Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,

LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.


Technology Review


- Emerging technologies and their applications for POC testing.


- Comprehensive listings of companies developing or marketing POC diagnostic technologies

  and products, by test.


Strategic Recommendations


- Specific opportunities for new POC instruments and reagent systems with potentially

  significant market appeal during the next five years.


- Design criteria for POC testing products.


- Alternative business expansion strategies.


- Potential market entry barriers and risks.


Competitive Assessments


- Assessments of major suppliers and emerging market entrants, including their sales, product

  portfolios, marketing tactics, joint ventures, and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - AdnaGen

   - Agilent Technologies

   - Beckman Coulter/Danaher

   - Biomedical Diagnostics

   - Biomerieux

   - Bio-Rad

   - Diasorin

   - Eiken Chemical

   - Fujirebio

   - Grifols

   - Instrumentation Laboratory

   - Kyowa Medex

   - Matritech/Alere

   - Ortho-Clinical Diagnostics

   - Quest Diagnostics

   - Roche

   - Siemens

   - Sysmex

   - ThermoFisher

   - Tosoh

   - Wako

   - Wallac/PE


Methodology


This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.


Contains 500 pages and 129 tables

“2015-2019 Decentralized/POC Clinical Chemistry and Immunodiagnostic Testing” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

2017 Analysis of the Global Tumor Marker Testing Market: Supplier Shares by Country, Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28500
  • Industry report
  • August 2017
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

2017-2021 World Tumor Markers Testing Market: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • July 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

Competing in the Global Cancer Diagnostics Market, 2017-2021

  • $ 21100
  • Industry report
  • June 2017
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.